Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
M.-F. Langelier, X. Lin, S. Zha, J. M. Pascal
This study shows clinical PARP inhibitors can allosterically retain PARP2 on DNA breaks, differing from their effect on PARP1, with implications for PARPi toxicity and design.
bioRxiv · Nov 8, 2022Biochemistry